Abstract
Background: Atherosclerotic disease is a leading cause of morbidity and mortality in adults and is generally thought of as only affecting adults. However, the pathologic changes in vessels leading to atherosclerosis, and an increased risk of cardiovascular disease, have been shown to begin in early adolescence.
Objectives: There is a growing body of literature suggesting that earlier treatment, through lifestyle changes and pharmacotherapy, can help reduce this risk. A growing number of children are presenting with elevated cholesterol because of the increased prevalence of obesity and diabetes mellitus. Methods: In addition, an increasing number of children are living with previously fatal diseases that increase the risk of atherosclerosis, either because of the disease process or as adverse effect of the treatment, such as human immunodeficiency virus, Kawasaki disease, and cardiac transplantation.
Result and Conclusion: In addition, specific disorders of cholesterol metabolism, such as Familial Hypercholesterolemia (FH) may be encountered in a pediatric practice.
Keywords: Atherosclerotic, cholesterol, Hypercholesterolemia, pharmacotherapy, atherosclerosis, disease.
Current Pediatric Reviews
Title:Treatment Strategies for Hypercholesterolemia
Volume: 13 Issue: 4
Author(s): Jacob Hartz and Sarah Clauss*
Affiliation:
- Children's National Medical Center, 111 Michigan Ave. NW, Washington, D.C. 20010,United States
Keywords: Atherosclerotic, cholesterol, Hypercholesterolemia, pharmacotherapy, atherosclerosis, disease.
Abstract: Background: Atherosclerotic disease is a leading cause of morbidity and mortality in adults and is generally thought of as only affecting adults. However, the pathologic changes in vessels leading to atherosclerosis, and an increased risk of cardiovascular disease, have been shown to begin in early adolescence.
Objectives: There is a growing body of literature suggesting that earlier treatment, through lifestyle changes and pharmacotherapy, can help reduce this risk. A growing number of children are presenting with elevated cholesterol because of the increased prevalence of obesity and diabetes mellitus. Methods: In addition, an increasing number of children are living with previously fatal diseases that increase the risk of atherosclerosis, either because of the disease process or as adverse effect of the treatment, such as human immunodeficiency virus, Kawasaki disease, and cardiac transplantation.
Result and Conclusion: In addition, specific disorders of cholesterol metabolism, such as Familial Hypercholesterolemia (FH) may be encountered in a pediatric practice.
Export Options
About this article
Cite this article as:
Hartz Jacob and Clauss Sarah*, Treatment Strategies for Hypercholesterolemia, Current Pediatric Reviews 2017; 13 (4) . https://dx.doi.org/10.2174/1573396314666180111143900
DOI https://dx.doi.org/10.2174/1573396314666180111143900 |
Print ISSN 1573-3963 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6336 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Melatonin and Renal Protection: Novel Perspectives from Animal Experiments and Human Studies (Review)
Current Pharmaceutical Design The Effects of Medications Used for the Management of Diabetes and Obesity on Postprandial Lipid Metabolism
Current Diabetes Reviews The Effects of Zataria Multiflora on Blood Glucose, Lipid Profile and Oxidative Stress Parameters in Adult Mice During Exposure to Bisphenol A
Cardiovascular & Hematological Disorders-Drug Targets Diabetes-Induced Alterations in Renal Medullary Microcirculation and Metabolism
Current Diabetes Reviews Pattern and Correlates of Hypomagnesemia Among Subset of Diabetes Mellitus
Current Diabetes Reviews Cerebral Arachidonate Cascade in Dementia: Alzheimers Disease and Vascular Dementia
Current Neuropharmacology Schistosoma mansoni Antigens as Modulators of the Allergic Inflammatory Response in Asthma
Endocrine, Metabolic & Immune Disorders - Drug Targets Tigecycline: A New Treatment Choice Against Acinetobacter baumannii
Recent Patents on Anti-Infective Drug Discovery Therapeutic Angiogenesis for Peripheral Artery Diseases by Autologous Bone Marrow Cell Transplantation
Current Pharmaceutical Design The Story of SPATA2 (Spermatogenesis-Associated Protein 2): From Sertoli Cells to Pancreatic Beta-Cells
Current Genomics The Mineralocorticoid Receptor in Endothelial Physiology and Disease: Novel Concepts in the Understanding of Erectile Dysfunction
Current Pharmaceutical Design The Anti-Inflammatory Potential of ACE2/Angiotensin-(1-7)/Mas Receptor Axis: Evidence from Basic and Clinical Research
Current Drug Targets Current Perspectives for Diabetes and Allostatic Load: The Role of Nutrition
Current Nutrition & Food Science Recent Advances on Detection of Modified Forms of Low-Density Lipoproteins
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery Myocardial Infarction. Pathological Relevance and Relationship with Coronary Risk Factors
Current Pharmaceutical Design The Impact of Cardiovascular Diseases on Cardiovascular Regulation During Exercise in Humans: Studies on Metaboreflex Activation Elicited by the Post-exercise Muscle Ischemia Method
Current Cardiology Reviews Coffee to Reduce Risk of Type 2 Diabetes? : A Systematic Review
Current Diabetes Reviews Leukocytes in Diabetic Retinopathy
Current Diabetes Reviews HPLC Stability Indicating Assay Method for Metformin Hydrochloride in Bulk Drug and Tablets and Cytotoxicity of Degradation Products
Current Pharmaceutical Analysis The Wnt/β-catenin Signalling Pathway Inhibitor Sclerostin is a Biomarker for Early Atherosclerosis in Obesity
Current Neurovascular Research